Astrazeneca (AZN) Return on Assets (2009 - 2026)

Astrazeneca (AZN) has reported Return on Assets for 18 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q1 2026 at Astrazeneca, up from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q2 2022, with the low at 0.0% in Q2 2025.
• Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2025.
• The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Assets stood at 0.0% in 2022, then tumbled by 1159 bps to 0.0% in 2023, then soared by 175 bps to 0.0% in 2024, then plunged by 215 bps to 0.0% in 2025, then jumped by 273 bps to 0.0% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.